Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03378089 · ClinicalTrials.gov registry record · NA
Music Therapy and Hematopoietic Stem Cell Transplant
A NA study of Hematopoietic Stem Cell Transplant, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT03378089: Completed NA study of Hematopoietic Stem Cell Transplant, sponsored by Case Comprehensive Cancer Center.
NCT03378089 is a NA study of Hematopoietic Stem Cell Transplant that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 56 participants, below the 97-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03378089, a NA study of Hematopoietic Stem Cell Transplant, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized, controlled study is to determine the effects of pre-transplant music therapy on mood, distress, and physical functioning variables in patients undergoing Hematopoietic Stem Cell Transplant (HSCT).
Primary Outcome
Distress Thermometer assessments for both the experimental and standard care group will be given in the mid-late afternoon. This is an analog scale from 0-10 where 0 indicates no distress and 10 indicates extreme distress.
Conditions Studied
Interventions
- BEHAVIORAL Music Therapy
- BEHAVIORAL No Music Therapy
Study Locations (1)
Ohio
- Cleveland Clinic, Taussig Cancer Institute, Case Comprehensive Cancer Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2018-02-26 |
| Est. Completion | 2019-06-21 |
| Phase | NA |
What the finished NCT03378089 record still lists
NCT03378089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 97-participant average among 8 other Hematopoietic Stem Cell Transplant trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Hematopoietic Stem Cell Transplant appearing as the primary indexed condition, and to 2 interventions - of which Music Therapy is the first listed.
NCT03378089 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03378089 about?
NCT03378089 is a clinical study titled "Music Therapy and Hematopoietic Stem Cell Transplant". The purpose of this randomized, controlled study is to determine the effects of pre-transplant music therapy on mood, distress, and physical functioning variables in patients undergoing Hematopoietic Stem Cell Transplant (HSCT).
What is the current status of trial NCT03378089?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2018-02-26. Estimated completion is 2019-06-21.
What conditions does trial NCT03378089 study?
This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplant.
What interventions are being tested in trial NCT03378089?
The interventions under investigation include: Music Therapy (BEHAVIORAL), No Music Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT03378089?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03378089 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03378089's enrollment target sits among peer trials
56 4th of 8 higher than 5 of 8 other Hematopoietic Stem Cell Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors
RECRUITING · NA
-
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
RECRUITING · NA
-
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
RECRUITING · NA
-
Vitamin A Replacement in Patients Undergoing HSCT and Its Role on MBI-LCBI Rates
COMPLETED · NA
-
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
RECRUITING · Phase 1
-
T Cell Therapy of Opportunistic Cytomegalovirus Infection
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI